Stryker

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Stryker 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About SYK

Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. 

CEO
Kevin A. Lobo
CEOKevin A. Lobo
Employees
56,000
Employees56,000
Headquarters
Portage, Michigan
HeadquartersPortage, Michigan
Founded
1941
Founded1941
Employees
56,000
Employees56,000

SYK Key Statistics

Market cap
113.13B
Market cap113.13B
Price-Earnings ratio
33.97
Price-Earnings ratio33.97
Dividend yield
1.17%
Dividend yield1.17%
Average volume
3.23M
Average volume3.23M
High today
$297.52
High today$297.52
Low today
$291.74
Low today$291.74
Open price
$294.79
Open price$294.79
Volume
2.18M
Volume2.18M
52 Week high
$404.87
52 Week high$404.87
52 Week low
$281.00
52 Week low$281.00

Stock Snapshot

As of today, Stryker(SYK) shares are valued at $295.10. The company's market cap stands at 113.13B, with a P/E ratio of 33.97 and a dividend yield of 1.2%.

During the trading session on 2026-06-03, Stryker(SYK) shares reached a daily high of $297.52 and a low of $291.74. At a current price of $295.10, the stock is +1.2% higher than the low and still -0.8% under the high.

Trading activity shows a volume of 2.18M, compared to an average daily volume of 3.23M.

The stock's 52-week range extends from a low of $281.00 to a high of $404.87.

The stock's 52-week range extends from a low of $281.00 to a high of $404.87.

SYK News

Simply Wall St 2h
Assessing Stryker Valuation After A Steady Multi‑Month Share Price Pullback

Advertisement Recent performance context for Stryker (SYK) Stryker (SYK) has seen its stock retreat recently, with the price down about 2% over the past day a...

Assessing Stryker Valuation After A Steady Multi‑Month Share Price Pullback
Nasdaq 5h
PAHC vs. SYK: Which Stock Should Value Investors Buy Now?

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Stryker (SYK). But which of the...

PAHC vs. SYK: Which Stock Should Value Investors Buy Now?
Simply Wall St 4d
Don't Ignore The Insider Selling In Stryker

We wouldn't blame Stryker Corporation ( ) shareholders if they were a little worried about the fact that Ronda Stryker, the Independent Director recently netted...

Don't Ignore The Insider Selling In Stryker

Analyst ratings

77%

of 30 ratings
Buy
76.7%
Hold
23.3%
Sell
0%

More SYK News

TipRanks 6d
Top Stryker Insider Unloads Massive Stake in High-Profile Stock Move

New insider activity at Stryker ( (SYK) ) has taken place on May 28, 2026. Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst rati...

Simply Wall St 6d
Does Stryker's New Pangea Trauma System in Europe Reveal a Deeper Design Advantage?

In May 2026, Stryker launched its Pangea Plating System in Europe, expanding access to a globally co-designed trauma plating platform for treating diverse fract...

Does Stryker's New Pangea Trauma System in Europe Reveal a Deeper Design Advantage?

People also own

Based on the portfolios of people who own SYK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.